Premium
Subthalamic beta band suppression reflects effective neuromodulation in chronic recordings
Author(s) -
Feldmann Lucia K.,
Neumann WolfJulian,
Krause Patricia,
Lofredi Roxanne,
Schneider GerdHelge,
Kühn Andrea A.
Publication year - 2021
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.14801
Subject(s) - deep brain stimulation , neuromodulation , medicine , neurostimulation , subthalamic nucleus , stimulation , beta (programming language) , parkinson's disease , beta rhythm , neuroscience , premovement neuronal activity , physical medicine and rehabilitation , rhythm , disease , psychology , computer science , programming language
Background and purpose Biomarkers for future adaptive deep brain stimulation still need evaluation in clinical routine. Here, we aimed to assess stimulation‐induced modulation of beta‐band activity and clinical symptoms in a Parkinson's disease patient during chronic neuronal sensing using a novel implantable pulse generator. Methods Subthalamic activity was recorded OFF and ON medication during a stepwise increase of stimulation amplitude. Off‐line fast fourier transfom ‐based analysis of beta‐band activity was correlated with motor performance rated from blinded videos. Results The stepwise increase of stimulation amplitude resulted in decreased beta oscillatory activity and improvement of bradykinesia. Mean low beta‐band (13–20 Hz) activity correlated significantly with bradykinesia (ρ = 0.662, p < 0.01). Conclusions Motor improvement is reflected in reduced subthalamic beta‐band activity in Parkinson's disease, supporting beta activity as a reliable biomarker. The novel PERCEPT neurostimulator enables chronic neuronal sensing in clinical routine. Our findings pave the way for a personalized precision‐medicine approach to neurostimulation.